Lobbying

Vanderbilt University Medical Center's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $230K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.

Vanderbilt University Medical Center

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$230K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Vanderbilt University Medical Center lobbying by quarter
Vanderbilt University Medical Center lobbying by quarter
QuarterAmountReports
Q4 2022$30K1
Q1 2023$50K1
Q2 2023$40K1
Q3 2023$40K1
Q4 2023$30K1
Q1 2024$70K1
Q2 2024$40K1
Q3 2024$50K1
Q4 2024$70K1
Q1 2025$170K1
Q2 2025$70K1
Q3 2025$30K1
Q4 2025$50K1
Q1 2026$120K1
Q2 2026$60K1
Q3 2026$00

By issue

  • Budget and appropriations$164.2K · 15 reports
  • Health issues$164.2K · 15 reports
  • Medical research and clinical labs$164.2K · 15 reports
  • Medicare and Medicaid$164.2K · 15 reports
  • Pharmacy$164.2K · 15 reports
  • Veterans$45.8K · 6 reports
  • Immigration$35.8K · 3 reports
  • Taxation$17.5K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Centers For Medicare and Medicaid Services (CMS)6 reports
  • White House Office3 reports
  • Health & Human Services, Dept of (HHS)2 reports
  • Food & Drug Administration (FDA)1 reports
  • Office of Management & Budget (OMB)1 reports

Firms it paid

Firm
In-houseVanderbilt University Medical Center$920K15 quarters

Former officials lobbying for it

Former position
ALEXANDER R. CURRIEVice President, VUMC Federal RelationsQ1 2026
NICHOLAS WARRENFedQ1 2026

Lobbying reports

Filed by
07/20for Q2In-house$60K
04/20for Q1In-house$120K
01/20for Q4 2025In-house$50K
25/10/20for Q3 2025In-house$30K
25/07/21for Q2 2025In-house$70K
25/04/21for Q1 2025In-house$170K
25/01/21for Q4 2024In-house$70K
25/01/21for Q4 2024In-house$30K
24/10/21for Q3 2024In-house$50K
24/07/22for Q2 2024In-house$40K
24/04/22for Q1 2024In-house$70K
24/01/22for Q4 2023In-house$30K
23/10/20for Q3 2023In-house$40K
23/07/20for Q2 2023In-house$40K
23/04/20for Q1 2023In-house$50K
23/01/20for Q4 2022In-house$30K